The serum biomarkers, particularly CA 15-3 and CEA, can be very helpful in monitoring treatment response and early detection of recurrence or metastasis in breast cancer before imaging techniques show a tumor progression [45,46]. Here, CEACAM5 is linked to breast carcinoma.